Predicting Mutations' Impact on IQ
Credit: Nogas1974 (Own work) [CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0)], via Wikimedia Commons
A recent study, co-edited by Canadian researchers (CHU Sainte-Justine, the Université de Montréal) and French researchers (the Institut Pasteur and the university Paris-Diderot), presents a model that can predict the effect of a genetic variant on a person’s cognitive traits and estimate the impact of genetic mutations on IQ. This discovery opens the way to a better interpretation of genetic analyses and better care for children at risk of developing neurodevelopmental disorders, from a very young age. These results have just been published in the science journal JAMA Psychiatry.
About 3% to 7% of the general population have neurodevelopmental and psychiatric disorders, including intellectual disabilities, autism spectrum disorder and schizophrenia. Genetic tests commonly performed in these patients identify in 10-15% of cases, mutations contributing to neurodevelopmental disorders. However, the effect of 90% of these mutations is not known because they are very rare. How can the effects of these rare and unknown variants on a person’s cognitive development be assessed?
A recent study published in the science journal JAMA Psychiatry, co-edited by researchers at CHU Sainte-Justine, the Université de Montréal, the Institut Pasteur and the Université Paris-Diderot, presents a model that can predict the effect of a genetic variant on a person’s cognitive traits.
“In practical terms, our model estimates the number of lost intellectual quotient (IQ) points induced by a deletion, wherever its location, in the patient’s genome. It relies on the fact that each gene defines a piece of biological information. When a gene is modified, its biological function risks being affected. If that function is related to cognition, the patient is exposed to a risk of having a neurodevelopmental disorder. Furthermore, these effects are cumulative, leading to an increased risk,” stated Guillaume Huguet, PhD, co-lead author of the study.
To reach these conclusions, the research team worked on two cohorts of the general population, with a total of 2,711 people. Initially, they identified variations (deletions and duplications) in the number of copies of genes in the subjects’ DNA. The research team explored the intrinsic characteristics of each deletion, such as the size, the number of genes lost or the haploinsufficiency score, that is, the organism’s intolerance for losing a copy of the gene and the resulting alteration of its biological function. The team then classified the results based on their “predictive power,” defining the genetic information that best characterizes the impact of deletion on the IQ.
To ascertain the relevance of the model, the researchers tested it against recurring deletions with a well-known impact on IQ. The rate of agreement between the observations in the literature and the model was 75%.
“We should point out that our model cannot predict the IQ of an individual, but rather the loss of IQ points associated with the presence of a deletion in the genome. If the mutation has a significant effect and is consistent with the cognitive impairment of the patient, we can consider that this mutation represents a major diagnostic factor in the patient,” explained Sébastien Jacquemont, MD, a clinician-scientist at CHU Sainte-Justine and a professor in the Department of Pediatrics at the Université de Montréal.
This discovery proposes a new method for the study of mutations whose rarity does not make it possible to use conventional approaches. It paves the way to a better interpretation of genetic analyses and to better care for children at risk of developing neurodevelopmental disorders, from a very young age.
The team is now pursuing its research to explore other behavioral phenotypes using this same genetic analysis approach.
“Our model will help clinicians estimate the cognitive impact of rare and undocumented genetic variants. This information will allow appropriate care to be put in place to try to compensate for the impact of these deleterious variants,” said Professor Thomas Bourgeron, head of the Human genetics and cognitive functions Unit at the Institut Pasteur.
This article has been republished from materials provided by Institut Pasteur. Note: material may have been edited for length and content. For further information, please contact the cited source.
Reference: Huguet, G., Schramm, C., Douard, E., Jiang, L., Labbe, A., Tihy, F., … Jacquemont, S. (2018). Measuring and Estimating the Effect Sizes of Copy Number Variants on General Intelligence in Community-Based Samples. JAMA Psychiatry. https://doi.org/10.1001/jamapsychiatry.2018.0039
A recent retrospective study evaluating continuous electroencephalography (cEEG) of children in intensive care units (ICUs) found a higher than anticipated number of seizures. The work also identified several conditions closely associated with the seizures, and suggests that cEEG monitoring may be a valuable tool for helping to identify and treat neurological problems in patients who are 14 months old or younger.
Pain is a negative feeling that we want to get rid of as soon as possible. In order to protect our bodies, we react for example by withdrawing the hand. This action is usually understood as the consequence of the perception of pain. A team from the Technical University of Munich (TUM) has now shown that perception, the impulse to act and provision of energy to do so take place in the brain simultaneously and not, as was expected, one after the other.